[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1107319T1 - Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων - Google Patents

Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων

Info

Publication number
CY1107319T1
CY1107319T1 CY20071100012T CY071100012T CY1107319T1 CY 1107319 T1 CY1107319 T1 CY 1107319T1 CY 20071100012 T CY20071100012 T CY 20071100012T CY 071100012 T CY071100012 T CY 071100012T CY 1107319 T1 CY1107319 T1 CY 1107319T1
Authority
CY
Cyprus
Prior art keywords
bacterial cells
cellular ingredients
cleaning bacterial
cleaning
ingredients
Prior art date
Application number
CY20071100012T
Other languages
English (en)
Inventor
Michael Schütz
Renate Grassl
Roman Meyer
Sibylle Frick
Ingrid Robl
Thomas Zander
Stefan Miller
Original Assignee
Profos Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Profos Ag filed Critical Profos Ag
Publication of CY1107319T1 publication Critical patent/CY1107319T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/802—Protein-bacteriophage conjugates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μέθοδο για τον εκλεκτικό καθαρισμό βακτηριακών κυττάρων και/ή κυτταρικών συστατικών, όπου ο καθαρισμός πραγματοποιείται μέσω κάποιου στερεού φορέα.
CY20071100012T 2001-06-24 2007-01-05 Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων CY1107319T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10129815A DE10129815A1 (de) 2001-06-24 2001-06-24 Verfahren zur Aufreinigung von Bakterienzellen und Zellbestandteilen
EP02750798A EP1399551B1 (de) 2001-06-24 2002-06-24 Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen

Publications (1)

Publication Number Publication Date
CY1107319T1 true CY1107319T1 (el) 2012-11-21

Family

ID=7688882

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100012T CY1107319T1 (el) 2001-06-24 2007-01-05 Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων

Country Status (11)

Country Link
US (2) US7579142B2 (el)
EP (1) EP1399551B1 (el)
AT (1) ATE344321T1 (el)
AU (1) AU2002350489B2 (el)
CA (1) CA2450572C (el)
CY (1) CY1107319T1 (el)
DE (2) DE10129815A1 (el)
DK (1) DK1399551T3 (el)
ES (1) ES2274983T3 (el)
PT (1) PT1399551E (el)
WO (1) WO2003000888A2 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50305695D1 (de) * 2002-06-24 2006-12-28 Profos Ag Verfahren zum nachweis und zur entfernung von endotoxin
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
DE10360844B4 (de) * 2003-12-20 2007-05-16 Profos Ag Verfahren zum Nachweis und zur Entfernung von Endotoxin
ES2523316T3 (es) * 2004-11-01 2014-11-24 Erber Aktiengesellschaft Bacteriófagos como agentes selectivos
DE102005002969A1 (de) 2005-01-21 2006-08-03 Profos Ag Verfahren zum Nachweis und zur Entfernung von Endotoxin
US20080093219A1 (en) * 2005-03-15 2008-04-24 Tufts University Magnetic Protein Nanosensors and Methods of Use
US7416883B2 (en) * 2005-05-24 2008-08-26 Steris Inc. Biological indicator
DE102006061002A1 (de) 2006-12-22 2008-06-26 Profos Ag Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien
US20100086149A1 (en) * 2007-03-20 2010-04-08 Jun Kuroda Acoustic processing system and method for electronic apparatus and mobile telephone terminal
MX2010002661A (es) 2007-09-14 2010-05-20 Adimab Inc Bancos de anticuerpos sinteticos, designados racionalmente y usos para los mismos.
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
ES2371292T3 (es) * 2008-07-04 2011-12-29 bioMérieux S.A. Nuevas proteínas de adhesión de bacteriófagos.
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
WO2014120794A1 (en) 2013-01-29 2014-08-07 Massachusetts Institute Of Technology Magnetic separation using nanoparticles
DE102013106462B3 (de) * 2013-06-20 2014-10-09 Airbus Defence and Space GmbH Detektionsverfahren zur Detektion von Bakterien, Verfahren zur Herstellung von Fusionsproteinen und Fusionsprotein
EP3456840A1 (en) * 2017-09-14 2019-03-20 Siemens Healthcare GmbH Method of enrichment of micro-organisms in whole blood
CN114231519B (zh) * 2021-11-28 2023-12-15 中国人民解放军军事科学院军事医学研究院 一种基于磁性微球共培养的粘性物质holdfast的富集方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162946C (no) * 1987-08-21 1990-03-14 Otto Soerensen Anordning for magnetisk separasjon av celler.
SE8704158L (sv) * 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Mikrosfaerer, foerfarande foer framstaellning daerav och anvaendning daerav
GB9003253D0 (en) 1990-02-13 1990-04-11 Amersham Int Plc Precipitating polymers
WO1993017129A1 (en) 1992-02-28 1993-09-02 Judkins Paul W Method and diagnostic kit for determination of bacteria
US5627024A (en) * 1994-08-05 1997-05-06 The Scripps Research Institute Lambdoid bacteriophage vectors for expression and display of foreign proteins
US5861285A (en) * 1994-09-16 1999-01-19 Tdk Corporation Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest
DE19520398B4 (de) * 1995-06-08 2009-04-16 Roche Diagnostics Gmbh Magnetisches Pigment
US5876925A (en) * 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
WO1998039482A1 (en) * 1997-03-07 1998-09-11 Sunol Molecular Corporation Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
GB9709728D0 (en) 1997-05-13 1997-07-02 Dynal As Single step method
IT1291913B1 (it) * 1997-05-22 1999-01-21 Angeletti P Ist Richerche Bio Metodo che prevede l'uso di batteriofagi per la rivelazione della presenza di molecole di interesse in campioni biologici
US7078224B1 (en) * 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
IL140918A0 (en) * 1998-07-27 2002-02-10 Genentech Inc Improved transformation efficiency in phage display through modification of a coat protein
DE19837751A1 (de) * 1998-08-20 2000-02-24 Siegfried Scherer Markierung, Immobilisierung, Anreicherung, Reinigung und Nachweis von Zellen mittels der Verwendung spezifischer Zellwand-bindender Domänen (CBD) von Zellwand-bindenden Proteinen aus Viren, Bakterien oder eukaryontischen Zellen
WO2000023792A1 (en) * 1998-10-19 2000-04-27 Cbd Technologies Ltd. Methods of concentrating microorganisms using affinity separation
DE19851156C1 (de) 1998-11-06 2000-04-27 Merck Patent Gmbh Verfahren zur Isolierung von Plasmid-DNA
DE19906352A1 (de) * 1999-02-17 1999-07-22 Kilian Dr Hennes Nachweis- und Zählgerät für suspendierte biologische Partikel
AU781090B2 (en) 1999-07-30 2005-05-05 Biomerieux S.A. Detection and identification of bacterial strains
GB0001450D0 (en) 2000-01-21 2000-03-08 Genpoint As Cell isolation method
EP1118676A2 (en) 2000-01-21 2001-07-25 Chemagen AG Cell isolation method
US6706437B2 (en) * 2001-01-10 2004-03-16 Sgl Carbon Ag Bipolar plates for fuel cell stacks

Also Published As

Publication number Publication date
WO2003000888A2 (de) 2003-01-03
ES2274983T3 (es) 2007-06-01
US20100047895A1 (en) 2010-02-25
US8932580B2 (en) 2015-01-13
DE50208601D1 (de) 2006-12-14
ATE344321T1 (de) 2006-11-15
CA2450572A1 (en) 2003-01-03
DE10129815A1 (de) 2003-01-09
EP1399551A2 (de) 2004-03-24
PT1399551E (pt) 2007-01-31
US7579142B2 (en) 2009-08-25
DK1399551T3 (da) 2007-03-05
AU2002350489B2 (en) 2007-01-18
CA2450572C (en) 2011-11-22
WO2003000888A3 (de) 2003-12-24
EP1399551B1 (de) 2006-11-02
US20040248298A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
CY1107319T1 (el) Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
BR0215405A (pt) Composições e processos de uso de collajolie
WO2004094635A3 (en) Compositions and methods for using a solid support to purify rna
NO20091976L (no) Nye forbindelser
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
BR0109975A (pt) Método para produzir ansamitocinas
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE60043868D1 (de) Abgeschwächte Mikroorganismen für die Behandlung von Infektionen
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
ECSP055584A (es) Proceso para la preparación de fibrinógeno
PT1248867E (pt) Reducao electroquimica selectiva de acidos 4-aminopicolinicos halogenados
PT1104762E (pt) Imidazo¬1,2a|azinas substituidas como inibidoras selectivas de cox 2
DE50310579D1 (de) Furancarboxamide
JO2400B1 (en) Polyethylene glycol derivatives
AU2003213333A1 (en) Method of purifying silicon, silicon produced by the method and solar cell
DE60023187D1 (de) Herstellung und reinigung von mycophenolsäure
EA200600777A1 (ru) N-замещённые пиразолилкарбоксанилиды
TW200420530A (en) Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
BR0316544A (pt) Compostos calcilìticos
ATE373700T1 (de) Organopolysiloxane-enthaltende zusammensetzung, verfahren zu ihrer herstellung und deren verwendung
DE60325737D1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
RS20060205A (en) Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens